Rnai
1 sirna therapeutics
develops ribozyme-based
develops ribozyme-based pharmaceuticals applicable to a wide range of human diseases. [nasdaq: rnai]
develops ribozyme-based pharmaceuticals applicable to a wide range of human diseases. [nasdaq: rnai]
2 sirna therapeutics, inc.
develop treatments
develop treatments based on rnai technology for asthma, diabetes, hepatitis c, macular degeneration and huntingtons disease. includes product pipeline, overview of company with research and manufacturing in boulder, colorado, headquartered in san francisco, california.
develop treatments based on rnai technology for asthma, diabetes, hepatitis c, macular degeneration and huntingtons disease. includes product pipeline, overview of company with research and manufacturing in boulder, colorado, headquartered in san francisco, california.